Breastscreen Wa Cohort Study Of Overdiagnosis And Mortality

Grant number: 1061375 | Funding period: 2014 - 2017



Overdiagnosis is the major downside of screening for breast cancer. This occurs when screening detects cancers that would not have caused symptoms in the woman's lifetime. This study aims to quantify the amount of overdiagnosis that occurs in the Australian breast cancer screening program (BreastScreen)